132 related articles for article (PubMed ID: 10742710)
1. Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure.
Witte K; Thackray S; Banerjee T; Clark AL; Cleland JG
Eur J Heart Fail; 2000 Mar; 2(1):107-12. PubMed ID: 10742710
[TBL] [Abstract][Full Text] [Related]
2. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
Rouleau JL; Pfeffer MA; Stewart DJ; Isaac D; Sestier F; Kerut EK; Porter CB; Proulx G; Qian C; Block AJ
Lancet; 2000 Aug; 356(9230):615-20. PubMed ID: 10968433
[TBL] [Abstract][Full Text] [Related]
3. [Omapatrilat for treatment of heart failure].
Yamazaki T
Nihon Rinsho; 2007 May; 65 Suppl 5():173-5. PubMed ID: 17571381
[No Abstract] [Full Text] [Related]
4. Comparison of losartan and captopril in ELITE II.
Meyer FP
Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022947
[No Abstract] [Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction.
McMurray JJ
Heart; 2001 Jul; 86(1):97-103. PubMed ID: 11410575
[No Abstract] [Full Text] [Related]
7. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
Pitt B; Poole-Wilson PA; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
Lancet; 2000 May; 355(9215):1582-7. PubMed ID: 10821361
[TBL] [Abstract][Full Text] [Related]
8. Omapatrilat for the management of heart failure and hypertension.
Husereau DR
Issues Emerg Health Technol; 2001 Jun; (17):1-4. PubMed ID: 11776285
[TBL] [Abstract][Full Text] [Related]
9. Omapatrilat--the story of Overture and Octave.
Coats AJ
Int J Cardiol; 2002 Nov; 86(1):1-4. PubMed ID: 12243845
[TBL] [Abstract][Full Text] [Related]
10. [Omapatrilat--new drug for patients with hypertension and heart failure].
Dzielska-Olczak M
Pol Merkur Lekarski; 2005 Oct; 19(112):556-8. PubMed ID: 16379325
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Losartan in the Elderly (ELITE) Trial: clinical implications.
Pitt B
Eur Heart J; 1997 Aug; 18(8):1197-9. PubMed ID: 9458406
[No Abstract] [Full Text] [Related]
12. [Interview with the author of ELITE II. Cave: small studies of fatal illnesses].
Pitt B
MMW Fortschr Med; 1999 Nov; 141(47):6. PubMed ID: 10912156
[No Abstract] [Full Text] [Related]
13. A review of vasopeptidase inhibitors: a new modality in the treatment of hypertension and chronic heart failure.
Nathisuwan S; Talbert RL
Pharmacotherapy; 2002 Jan; 22(1):27-42. PubMed ID: 11794428
[TBL] [Abstract][Full Text] [Related]
14. [Vasopeptidase inhibitors. Omapatrilat in hypertension and heart failure].
Heinzl S
Med Monatsschr Pharm; 2000 Feb; 23(2):38-41. PubMed ID: 10701306
[No Abstract] [Full Text] [Related]
15. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
Thackray S; Witte K; Clark AL; Cleland JG
Eur J Heart Fail; 2000 Jun; 2(2):209-12. PubMed ID: 10856736
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
Houghton AR; Harrison M; Cowley AJ
Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
[TBL] [Abstract][Full Text] [Related]
17. Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
Dickstein K; Kjekshus J;
Am J Cardiol; 2001 Mar; 87(6):766-71, A7. PubMed ID: 11249900
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor antagonists for heart failure.
Struthers AD
Heart; 1998 Jul; 80(1):5-6. PubMed ID: 9764049
[No Abstract] [Full Text] [Related]
19. [The ELITE 2 study].
Mahé I
Presse Med; 2000 Sep; 29(25):1407. PubMed ID: 11036516
[No Abstract] [Full Text] [Related]
20. [Management of hypertensive patients with cardiovascular damage].
Tomiyama H; Takata Y; Yamashina A
Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
